Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Île-de-France5982
John Chalmers65
Île-de-France Sauf John Chalmers" 5940
John Chalmers Sauf Île-de-France" 23
Île-de-France Et John Chalmers 42
Île-de-France Ou John Chalmers 6005
Corpus22736
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 42.
Ident.Authors (with country if any)Title
000545 Tom J. Moullaali [Australie] ; Shoichiro Sato [Australie] ; Xia Wang [Australie] ; Alejandro A. Rabinstein [États-Unis] ; Hisatomi Arima [Australie] ; Cheryl Carcel [Australie] ; Guofang Chen [République populaire de Chine] ; Thompson Robinson [Royaume-Uni] ; Emma Heeley [Australie] ; Edward Chan [Australie] ; Candice Delcourt [Australie] ; Christian Stapf [France] ; Charlotte Cordonnier [France] ; Richard I. Lindley [Australie] ; John Chalmers [Australie] ; Craig S. Anderson [Australie]Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies.
000F48 Kamel Mohammedi [Australie, France] ; Mark Woodward [Australie, Royaume-Uni, États-Unis] ; Michel Marre [France] ; Stephen Colagiuri [Australie] ; Mark Cooper ; Stephen Harrap ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
001025 Min Jun [Australie] ; Toshiaki Ohkuma [Australie] ; Sophia Zoungas [Australie] ; Stephen Colagiuri [Australie] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; David Matthews [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Anthony Rodgers [Australie] ; Vlado Perkovic [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie]Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
001324 Pavel Hamet ; Mounsif Haloui ; François Harvey ; François-Christophe Marois-Blanchet ; Marie-Pierre Sylvestre ; Muhammad-Ramzan Tahir ; Paul H. G. Simon ; Beatriz Sonja Kanzki [Canada] ; John Raelson ; Carole Long ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Michel Marre [France] ; Stephen Harrap [Australie] ; Johanne TremblayPROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study
001905 Kamel Mohammedi [Australie] ; Mark Woodward [Australie, Royaume-Uni, États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Stephen Colagiuri [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap ; Neil Poulter [Royaume-Uni] ; David R. Matthews [Royaume-Uni] ; Michel Marre [France] ; John Chalmers [Australie]Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
001B17 Kamel Mohammedi [Australie] ; Mark Woodward [États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Bryan Williams [Royaume-Uni] ; Liu Lisheng [République populaire de Chine] ; Anthony Rodgers [Australie] ; Giuseppe Mancia [Italie] ; Bruce Neal [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; John Chalmers [Australie]Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
001B71 Danni Zheng [Australie] ; Hisatomi Arima [Australie, Japon] ; Shoichiro Sato [Australie] ; Antonio Gasparrini [Royaume-Uni] ; Emma Heeley [Australie] ; Candice Delcourt [Australie] ; Serigne Lo [Australie] ; Yining Huang [République populaire de Chine] ; Jiguang Wang [République populaire de Chine] ; Christian Stapf [France, Canada] ; Thompson Robinson [Royaume-Uni] ; Pablo Lavados [Chili] ; John Chalmers [Australie] ; Craig S. Anderson [Australie]Low Ambient Temperature and Intracerebral Hemorrhage: The INTERACT2 Study
001B82 Muh Geot Wong [Australie] ; Vlado Perkovic [Australie] ; John Chalmers [Australie] ; Mark Woodward [États-Unis] ; Qiang Li [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; David Matthews [Royaume-Uni] ; Bruce Neal [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Anthony Rodgers [Australie] ; Bryan Williams [Royaume-Uni] ; Sophia Zoungas [Australie]Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
001F63 Joep Van Der Leeuw [Pays-Bas] ; Frank L J. Visseren [Pays-Bas] ; Mark Woodward [Australie] ; Yolanda Van Der Graaf [Pays-Bas] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Michel Marre [France] ; Neil Poulter [Royaume-Uni] ; Sophia Zoungas [Australie] ; John Chalmers [Australie]Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
002427 Kamel Mohammedi [Australie] ; Mark Woodward [Australie] ; Sophia Zoungas [Australie] ; Qiang Li [Australie] ; Stephen Harrap [Australie] ; Anushka Patel [Australie] ; Michel Marre [France] ; John Chalmers [Australie]Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
002897 Merlin C. Thomas [Australie] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; Qiang Li [Australie] ; Raelene Pickering [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Vlado Perkovic [Australie] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie] ; John Chalmers [Australie] ; Graham S. Hillis [Australie]Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
002918 Yining Huang [République populaire de Chine] ; Vijay K. Sharma [Singapour] ; Thompson Robinson [Royaume-Uni] ; Richard I. Lindley [Australie] ; Xiaoying Chen [Australie] ; Jong Sung Kim [Corée du Sud] ; Pablo Lavados [Chili] ; Ver Nica Olavarría [Chili] ; Hisatomi Arima [Australie] ; Sully Fuentes [Australie] ; Huy Thang Nguyen [Viêt Nam] ; Tsong-Hai Lee [Taïwan] ; Mark W. Parsons [Australie] ; Christopher Levi [Australie] ; Andrew M. Demchuk [Canada] ; Philip M W. Bath [Royaume-Uni] ; Joseph P. Broderick [États-Unis] ; Geoffrey A. Donnan [Australie] ; Sheila Martins [Brésil] ; Octavio M. Pontes-Neto [Brésil] ; Federico Silva [Colombie] ; Jeyaraj Pandian [Inde] ; Stefano Ricci [Italie] ; Christian Stapf [France] ; Mark Woodward [Australie] ; Jiguang Wang [République populaire de Chine] ; John Chalmers [Australie] ; Craig S. Anderson [Australie]Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
002998 Emma Heeley [Australie] ; Craig S. Anderson [Australie] ; Mark Woodward [Australie] ; Hisatomi Arima [Australie] ; Thompson Robinson [Royaume-Uni] ; Christian Stapf [France] ; Mark Parsons [Australie] ; Pablo M. Lavados [Chili] ; Yining Huang [République populaire de Chine] ; Yanxia Wang [République populaire de Chine] ; Sophie Crozier [France] ; Adrian Parry-Jones [Royaume-Uni] ; Jiguang Wang [République populaire de Chine] ; John Chalmers [Australie]Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trial.
003A19 Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; Qiang Li [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni]Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial.
003A59 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Stephen Harrap [Australie] ; Lisheng Liu [République populaire de Chine] ; Bruce Neal [Australie] ; John Chalmers [Australie]Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial.
003B72 Lisa Manning [Royaume-Uni] ; Yoichiro Hirakawa [Australie] ; Hisatomi Arima [Australie] ; Xia Wang [Australie] ; John Chalmers [Australie] ; Jiguang Wang [République populaire de Chine] ; Richard Lindley [Australie] ; Emma Heeley [Australie] ; Candice Delcourt [Australie] ; Bruce Neal [Australie] ; Pablo Lavados [Chili] ; Stephen M. Davis [Australie] ; Christophe Tzourio [France] ; Yining Huang [République populaire de Chine] ; Christian Stapf [France] ; Mark Woodward [Australie] ; Peter M. Rothwell [Royaume-Uni] ; Thompson G. Robinson [Royaume-Uni] ; Craig S. Anderson [Australie]Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial.
003F49 GUOFANG CHEN [République populaire de Chine, Australie] ; Hisatomi Arima [Australie] ; GUOJUN WU [Australie, République populaire de Chine] ; Emma Heeley [Australie] ; Candice Delcourt [Australie] ; PEIYING ZHANG [République populaire de Chine] ; Alejandro A. Rabinstein [États-Unis] ; Thompson Robinson [Royaume-Uni] ; Christian Stapf [France] ; YINING HUANG [République populaire de Chine] ; LILI SONG [Australie, République populaire de Chine] ; JIE YANG [Australie, République populaire de Chine] ; XIA WANG [Australie] ; QIANG LI [Australie] ; XIAOYING CHEN [Australie] ; John Chalmers [Australie] ; Craig Anderson [Australie]Subarachnoid Extension of Intracerebral Hemorrhage and 90-Day Outcomes in INTERACT2
004115 Sophia Zoungas [Australie] ; Mark Woodward [Australie, États-Unis] ; QIANG LI [Australie] ; Mark E. Cooper [Australie] ; Pavel Hamet [Canada] ; Stephen Harrap [Australie] ; Simon Heller [Royaume-Uni] ; Michel Marre [France] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie]Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
004199 Paul Welsh [Royaume-Uni] ; Mark Woodward [Australie] ; Graham S. Hillis [Australie] ; QIANG LI [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Neil Poulter [Royaume-Uni] ; Louise Ryan [Australie] ; Stephen Harrap [Australie] ; Ansuhka Patel [Australie] ; John Chalmers [Australie] ; Naveed Sattar [Royaume-Uni]Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial
004255 Gordon Lowe [Royaume-Uni] ; Mark Woodward [Australie] ; Graham Hillis [Australie] ; Ann Rumley [Royaume-Uni] ; QIANG LI [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; Pavel Hamet [Canada] ; Anushka Patel [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie]Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
004C24 Jamie Morton [Australie] ; Martin K. C. Ng [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Giuseppe Mancia [Italie] ; Neil R. Poulter [Royaume-Uni] ; Michel Marre [France] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie]The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality?
004D17 Craig S. Anderson [Australie] ; Emma Heeley [Australie] ; YINING HUANG [République populaire de Chine] ; JIGUANG WANG [République populaire de Chine] ; Christian Stapf [France] ; Candice Delcourt [Australie] ; Richard Lindley [Australie] ; Thompson Robinson [Royaume-Uni] ; Pablo Lavados [Chili] ; Bruce Neal [Australie] ; Jun Hata [Australie, Japon] ; Hisatomi Arima [Australie] ; Mark Parsons [Australie] ; YUECHUN LI ; JINCHAO WANG [République populaire de Chine] ; Stephane Heritier [Australie] ; QIANG LI [Australie] ; Mark Woodward [Australie, États-Unis] ; R. John Simes [Australie] ; Stephen M. Davis [Australie] ; John Chalmers [Australie]Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
005990 Meg J. Jardine [Australie] ; Jun Hata [Australie] ; Mark Woodward [Australie] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Hisatomi Arima [Australie] ; Sophia Zoungas [Australie] ; Alan Cass [Australie] ; Anushka Patel [Australie] ; Michel Marre [France] ; Giuseppe Mancia [Italie] ; Carl E. Mogensen [Danemark] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie]Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
005D02 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial
006635 Sébastien Czernichow [Australie, France] ; Alberto Zanchetti [Italie] ; Fiona Turnbull [Australie] ; Federica Barzi [Australie] ; Toshiaru Ninomiya [Australie] ; André-Pascal Kengne [Australie] ; Hiddo J. Lambers Heerspink [Pays-Bas] ; Vlado Perkovic [Australie] ; Rachel Huxley [Australie] ; Hisatomi Arima [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie]The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
006707 Daniel G. Hackam [Canada] ; Mark Woodward [Australie] ; L. Kristin Newby [États-Unis] ; Deepak L. Bhatt [États-Unis] ; Mingyuan Shao [États-Unis] ; Eric E. Smith [Canada] ; Allan Donner [Canada] ; Muhammad Mamdani [Canada] ; James D. Douketis [Canada] ; Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; David L. Tirschwell [États-Unis] ; Bruce M. Psaty [États-Unis] ; Cheryl D. Bushnell [États-Unis] ; Maria I. Aguilar [États-Unis] ; Dan J. Capampangan [États-Unis] ; David J. Werring [Royaume-Uni] ; Paola De Rango [Italie] ; Anand Viswanathan [États-Unis] ; Nicolas Danchin [France] ; Ching-Lan Cheng [Taïwan] ; Yea-Huei Kao Yang [Taïwan] ; B. Marianne Verdel [Pays-Bas] ; Mei-Shu Lai [Taïwan] ; James Kennedy [Royaume-Uni] ; Shinichiro Uchiyama [Japon] ; Takenori Yamaguchi [Japon] ; Yasuo Ikeda [Japon] ; Marko Mrkobrada [Canada]Statins and Intracerebral Hemorrhage Collaborative Systematic Review and Meta-Analysis
006D86 Jasper J. Brugts [Pays-Bas] ; Aaron Isaacs [Pays-Bas] ; Moniek P. M. De Maat [Pays-Bas] ; Eric Boersma [Pays-Bas] ; Cock M. Van Duijn [Pays-Bas] ; K. Martijn Akkerhuis [Pays-Bas] ; Andre G. Uitterlinden [Pays-Bas] ; Jacqueline C. M. Witteman [Pays-Bas] ; Francois Cambien [France] ; Claudio Ceconi [Italie] ; Willem Remme [Pays-Bas] ; Michel Bertrand [France] ; Toshiharu Ninomiya [Australie] ; Stephen Harrap [Australie] ; John Chalmers [Australie] ; Stephen Macmahon [Australie] ; Kim Fox [Royaume-Uni] ; Roberto Ferrari [Italie] ; Maarten L. Simoons [Pays-Bas] ; A. H. Jan Danser [Pays-Bas]A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
007372 André-Pascal Kengne [Australie] ; Sébastien Czernichow [Australie, France] ; John Chalmers [Australie]Variables tensionnelles et risque cardiovasculaire chez les diabétiques de type 2 dans l'étude ADVANCE
007548 Sophia Zoungas [Australie] ; Anushka Patel [Australie] ; John Chalmers [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; QIANG LI [Australie] ; M. Biostat [Australie] ; Laurent Billot [Australie] ; Mark Woodward [États-Unis] ; Toshiharu Ninomiya [Australie] ; Bruce Neal [Australie] ; Stephen Macmahon [Australie] ; Diederick E. Grobbee [Pays-Bas] ; Andre Pascal Kengne [Australie] ; Michel Marre [France] ; Simon Heller [Royaume-Uni]Severe Hypoglycemia and Risks of Vascular Events and Death
007644 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie]Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
007801 Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
007877 G. David Batty [Royaume-Uni, Australie] ; QIANG LI [Australie] ; Sébastien Czernichow [Australie, France] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Rachel Huxley [Australie] ; Anushka Patel [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Mark Woodward [Australie, États-Unis] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Neil Poulter [Royaume-Uni] ; John Chalmers [Australie]Erectile Dysfunction and Later Cardiovascular Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) Trial
007911 Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
008100 Carole Dufouil [France] ; Ophélia Godin [France] ; John Chalmers [Australie] ; Oghuzan Coskun [France] ; Stephen Macmahon [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Marie-Germaine Bousser [France] ; Craig Anderson [Australie] ; Bernard Mazoyer [France] ; Christophe Tzourio [France]Severe Cerebral White Matter Hyperintensities Predict Severe Cognitive Decline in Patients With Cerebrovascular Disease History
008235 Bastiaan E. De Galan [Australie, Pays-Bas] ; Vlado Perkovic [Australie] ; Toshiharu Ninomiya [Australie] ; Avinesh Pillai [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Stephen Harrap [Australie] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie] ; Paul Glasziou [Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
008421 Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie]Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
008447 Andre-Pascal Kengne [Australie] ; Sébastien Czernichow [France] ; Rachel Huxley [Australie] ; Diederick Grobbee [Pays-Bas] ; Mark Woodward [États-Unis] ; Bruce Neal [Australie] ; Sophia Zoungas [Australie] ; Mark Cooper [Australie] ; Paul Glasziou [Royaume-Uni] ; Pavel Hamet [Canada] ; Stephen B. Harrap [Australie] ; Giuseppe Mancia [Italie] ; Neil Poulter [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; John Chalmers [Australie]Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE
008475 Toshiharu Ninomiya [Australie] ; Vlado Perkovic [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Sophia Zoungas [Australie] ; Avinesh Pillai [Australie] ; Meg Jardine [Australie] ; Anushka Patel [Australie] ; Alan Cass [Australie] ; Bruce Neal [Australie] ; Neil Poulter [Royaume-Uni] ; Carl-Erik Mogensen [Danemark] ; Mark Cooper [Australie] ; Michel Marre [France] ; Bryan Williams [Royaume-Uni] ; Pavel Hamet [Canada] ; Giuseppe Mancia [Italie] ; Mark Woodward [Australie, États-Unis] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
009C83 Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial
00A499 Pierre Amarenco [France] ; Anushka Patel [France] ; Mark Woodward [France] ; Duncan J. Campbell [Australie] ; David R. Sullivan [Australie] ; Samuel Colman [France] ; John Chalmers [France] ; Bruce Neal [France] ; Stephen Macmahon [France]Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease
00A663 Carole Dufouil [France] ; John Chalmers [Australie] ; Oguzhan Coskun [France] ; Véronique Besancon [France] ; Marie-Germaine Bousser [France] ; Pierre Guillon [France] ; Stephen Macmahon [Australie] ; Bernard Mazoyer [France] ; Bruce Neal [Australie] ; Mark Woodward [Australie] ; Nathalie Tzourio-Mazoyer [France] ; Christophe Tzourio [France, Australie]Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) magnetic resonance imaging substudy
00B023 Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie]The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024